期刊文献+

下调miR-153促进高糖诱导的肾小管上皮细胞-间充质转化 被引量:4

Down-regulation of miR-153 Contributes to High Glucose- mediated Renal Tubule EMT
下载PDF
导出
摘要 目的:探讨miR-153调控高糖诱导肾小管上皮细胞(HK2)-间充质转化(EMT)的机制,为研究糖尿病肾病(DN)间质纤维化机制提供新思路。方法:采用生物信息学方法预测调控Snail的候选miRNAs;在db/db小鼠肾组织中验证所有候选miRNAs的表达并分别与Snail做pearson相关性分析,筛选出与Snail负相关最显著的miRNA;以高糖诱导的HK2细胞为载体,转染该miRNA mimics 72 h后,采用real-time PCR、western blot方法,观察该miRNAs、Snail以及E-cadherin的表达改变。结果:调控Snail的候选miRNAs共7个,分别是:miR-153、miR-30e、miR-30d、miR-30b、miR-384-5p、miR-30a、miR-30c;与db/m相比,miR-153、miR-30d及miR-30e在db/db小鼠肾皮质中表达显著下调(P<0.05),其中miR-153与Snail表达水平负相关最显著(r=-0.501 56);高糖诱导HK2细胞下调miR-153,肾小管上皮细胞标志蛋白E-cadherin表达减少;过表达miR-153抑制HK2细胞表达Snail,而E-cadherin水平增加。结论:MiR-153可能通过靶基因Snail参与调控高糖诱导的HK2细胞EMT。 Objective:To investigate mechanism by which miR-153 regulates high glucose-induced the epithelial-mesenchymal transition(EMT) in human renal proximal tubule cell(HK2),providing a novel insight into interstitial fibrosis in the process of DN.Methods:We used bioinformatics to predict the candidates of miRNAs potentially targeting Snail,followed by confirming the expressions of all of miRNA candidates in renal cortex of db/db mice;Pearson relavant analysis was performed between miRNAs and Snail respectively.We further focus on miRNA showing the most significantly negative relevance with Snail.The selected miRNA and Snail mRNA were detected in HK2 cells exposure to high glucose condition by using real-time PCR.The protein levels of Snail,E-cadherin in HK2 cells were measured 72 hours after transfection of selected miRNA mimics.Results:A total of 7 miRNA candidates potentially targeting Snail were screened by bioinformatics,which were miR-153,miR-30e,miR-30d,miR-30b,miR-384-5p,miR-30a,miR-30c.Among these candidates,miR-153、miR-30d and miR-30e down-regulated remarkably in renal cortex in db/db mice compare with db/m controls(P0.05).Pearson analysis indicated only miR-153 showing the most significantly negative relevance with Snail(r=-0.501 56).The similar results were found in high glucose-induced HK2 cells.Overexpression of miR-153 decreased the levels of Snail,whereas E-cadherin increased in cultured HK2 cells instead.Conclusion:The current study reveals that miR-153 might involve in the regulation of high glucose-mediated tubule epithelial cell EMT via targeting Snail.
出处 《中国中西医结合肾病杂志》 2013年第10期850-854,I0001,共6页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 上海市国际科技合作项目(No.11410708500) 国家自然科学基金面上项目(No.81270814 81270824)
  • 相关文献

参考文献12

  • 1Schena EP,Gesualdo L.Pathogenetic mechanisms of diabetic nephropathy.J Am Soc Nephrol,2005,16 (Suppl 1):S30-S33.
  • 2Kalluri R,Neilson EG.Epithelial-mesenchymal transition and its implications for fibrosis.J Clin Invest,2003,112(12):1776-1784.
  • 3Badid C,Demouliere A,Babici D,et al.Interstitial expression of alpha-SMA:an early marker of chronic renal allograst dysfunction.Nephrol Dial Transplant,2002,17(11):1993-1998.
  • 4Cornijn J,Berx G,Vermassen P,et al.The two-handed E box binding xine finger protein SIP1 down-regulates E-cadherin and induces invation.Mol Cell,2001,7(6):1267-1278.
  • 5Kato M,Zhang J,Wang M,et al.MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.Proc Natl Acad Sci,2007,104(9):3432-3437.
  • 6高清,刘志红,秦卫松,郑春霞,张明超,曾彩虹,王生余,王建平,朱晓东,黎磊石.雷公藤甲素治疗db/db糖尿病小鼠的疗效观察[J].肾脏病与透析肾移植杂志,2009,18(6):519-528. 被引量:15
  • 7Yang J,Liu Y.Blockage of tubular epithelial to myofibroblast transition by hepatocyte gowth factor prevent from renal interstial fibrosis.J Am Soc Nephrol,2002,13(1):96-107.
  • 8Rastaldi MP,Ferrario F,Giardino L,et al.Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies.Kidney Int,2002,62(1):137-146.
  • 9Lassila M,Jandeleit-Dahm K,Seah KK,et al.Imatinib attenuates diabetic nephropathy in apolipoprotein E knockout mice.J Am Soc Nephrol,2005,16(2):363-373.
  • 10Gregory PA,Bert AG,Paterson EL,et al.The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.Nat Cell Biol,2008,10(5):593-601.

二级参考文献39

  • 1宋海翔,龚静,陈雯,王子芬,李延国,左振素.雷公藤多甙对糖尿病肾病患者尿单核细胞趋化蛋白-1的影响[J].中国中西医结合杂志,2005,25(5):416-418. 被引量:47
  • 2Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease : a mechanistic viewpoint. Kidney Int,2008,74( 1 ) :22 - 36.
  • 3Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008,57 (6) :1446 -1454.
  • 4Rivero A, Mora C, Muros M ,et al. Palhogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci ,2009,116(6):479-492.
  • 5American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care,2007,30( Suppl 1 ) :S4 - S41.
  • 6Han SY ,So GA,Jee YH,et al. Effect of retinoic acid in experimental diabetic nephropathy, Immunol Cell Biol, 2004,82 ( 6 ) :568 - 576.
  • 7Brezniceanu ML, Liu F, Wei CC, et al. Catalase overexpression attenuales angintensinogen expression and apoptosis in diabetic mice. Kidney Int,2007,71 (9) :912 - 923.
  • 8Winer S, Chan Y,Paltser G,et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med, 2009, 15 (8) : 921 -929.
  • 9Chen ZH,Qin WS,Zeng CH, et al. Triptolide reduces proteinuria in experimental membranous nephropathy and protects CSb-9-induced podocyte injuries in vitro. Kidney Int. (underreview).
  • 10Zheng CX,Chen ZH, Zeng CH, et al. Triptolide protects podocytcs from puromycinaminonuclcoside induced injory in vivo and in vitro. Kidney Int,2008,74 ( 5 ) :596 - 612.

共引文献14

同被引文献48

  • 1Gregory RI, Yan KP, Amuthan G, et al. The Microprocessor com- plex mediates the genesis of microRNAs. Nature, 2004, 432 (7014) :235 - 240.
  • 2Du T, Zamore PD. microPrimer:the biogenesis and function of microRNA. Development, 2005,132 ( 21 ) :4645 - 4652.
  • 3Filipowiez W. RNAi:the nuts and bolts of the RISC machine. Cell,2005,122( 1 ) :17 -20.
  • 4Tian Z, Greene AS, Pietrusz JL, et al. MicroRNA -target pairs in the rat kidney identified by microRNA mieroarray, proteomie, and bioinformatie analysis. Genome Res,2008,18 (3) :404 - 411.
  • 5Lorenzen JM, Hailer H, Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol, 2011,7(5) :286 -294.
  • 6Bhatt K, Mi QS, Dong Z. microRNAs in kidneys: biogenesis, regu- lation,and pathophysiological roles. Am J Physiol Renal Physiol, 2011,300(3) :F602 - F610.
  • 7Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol,2011,7 (12) :684 - 696.
  • 8Meng XM, Huang XR, Xiao J, et al. Disruption of Smad4 impairs TGF- β/Smad3 and Smad7 transcriptional regulation during re- nal inflammation and fibrosis in vivo and in vitro. Kidney Int, 2012,81 (3) :266 - 279.
  • 9Li R, Lan HY, Chung AC. Distinct roles of Smads and microR- NAs in TGF - β signaling during kidney diseases. Hong Kong Journal of Nephrology,2013,15 ( 1 ) : 14 - 21.
  • 10Chung AC, Dong Y, Yang W, et al. Smad7 suppresses renal fi- brosis via altering expression of TGF - β/Smad3 - regulated mi- croRNAs. Mol Ther,2013,21 (2) :388 -398.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部